Supplementary Figure from Initial Phase I Safety Study of Gedatolisib plus Cofetuzumab Pelidotin for Patients with Metastatic Triple-Negative Breast Cancer
Authors:
- Milan RadovichMRMilan Radovich
- Jeffrey P. SolzakJSJeffrey P. Solzak
- Chao J. WangCWChao J. Wang
- Bradley A. HancockBHBradley A. Hancock
- Sunil BadveSunil Badve
- Sandra K. AlthouseSASandra K. Althouse
- Steven M. BraySBSteven M. Bray
- Anna Maria V. StornioloASAnna Maria V. Storniolo
- Tarah J. BallingerTBTarah J. Ballinger
- Bryan P. SchneiderBSBryan P. Schneider
- Kathy D. MillerKMKathy D. Miller
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)